Deutsch Peter E. 13D/13G Filings for Aeglea BioTherapeutics, Inc. (AGLE)

Deutsch Peter E. 13D and 13G filings for Aeglea BioTherapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-11-14
3:13 pm
Purchase
2023-09-08 13G Aeglea BioTherapeutics, Inc.
AGLE
Deutsch Peter E. 383,659
9.480%
383,659increase
(New Position)
Filing